Access cutting-edge lung cancer treatment through this clinical trial at a research site in Canton. Study-provided care at no cost to qualified participants.
Access lung cancer specialists in Canton at no cost
This study follows strict safety protocols and ethical guidelines
All study-related lung cancer treatment provided free
The Sponsor is developing KB707, a replication-defective, non-integrating herpes simplex virus type 1 (HSV-1)-derived vector that is designed to stimulate an anti-tumor immune response through the production of cytokines delivered to the airways of people with advanced solid tumor malignancies affecting the lungs via nebulization. This Phase 1/2, open-label, multicenter, dose escalation and expansion study is designed to evaluate the safety and tolerability of KB707 in adults with with advanced
Sponsor: Krystal Biotech, Inc.
Check if you qualify for this lung cancer clinical trial in Canton, OH
If you're searching for lung cancer treatment options in Canton, OH, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Canton research site is actively enrolling participants for this clinical trial. You'll receive care from experienced lung cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.